Targeting Amyloidogenic Processing of APP in Alzheimer’s Disease
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2020.00137
Abstract: Alzheimer’s disease (AD) is the most common type of senile dementia, characterized by neurofibrillary tangle and amyloid plaque in brain pathology. Major efforts in AD drug were devoted to the interference with the production and… read more here.
Keywords: alzheimer disease; app; disease; targeting amyloidogenic ... See more keywords